| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/10/2002 | WO2002002095A2 Compositions for treating bacterial infections containing oxazolidinone compound, sulbactam and an ampicillin |
| 01/10/2002 | WO2002002055A2 Antifungal compounds and methods of use |
| 01/10/2002 | WO2001094636A8 Compositions, kits, and methods for identification and modulation of type i diabetes |
| 01/10/2002 | WO2001059071A3 Methods of preparing and using a viral vector library |
| 01/10/2002 | WO2001058485A3 Prophylactic and therapeutic antibodies against vaccina virus antigens |
| 01/10/2002 | WO2001056993A3 Pyrazole compositions useful as inhibitors of erk |
| 01/10/2002 | WO2001043691A3 Fragments and antagonists of heat shock protein 60 |
| 01/10/2002 | WO2001040279A3 Hbv sequences |
| 01/10/2002 | WO2001038358A3 Hbv/hcv virus-like particle |
| 01/10/2002 | WO2001036625A3 ANTISENSE OLIGONUCLEOTIDE SEQUENCES DERIVED FROM groEL AND groES AS INHIBITORS MICROORGANISMS |
| 01/10/2002 | WO2001036452A3 Heteroclitic analogs of class i epitodes |
| 01/10/2002 | WO2001036425A3 Imidazole compounds used as phosphodiesterase vii inhibitors |
| 01/10/2002 | WO2001034118A3 Solid dispersion pharmaceutical formulations |
| 01/10/2002 | WO2001000615A8 Respiratory syncytial virus replication inhibitors |
| 01/10/2002 | WO2000075347A3 Tet repressor-based transcriptional regulatory proteins |
| 01/10/2002 | WO2000055332A3 Human regulators of intracellular phosphorylation |
| 01/10/2002 | WO2000042864A3 Methods for reducing mortality rates in poultry |
| 01/10/2002 | US20020004584 HIV immune adjuvant therapy |
| 01/10/2002 | US20020004581 Polypeptide; for use in te diagnosis and treatment of microorganismal infections; bactericides |
| 01/10/2002 | US20020004580 Polypeptide; for use in the diagnosis and treatment of microorganismal infections; bactericides |
| 01/10/2002 | US20020004514 Anticancer compound and enantiomer separation method useful for synthesizing said compound |
| 01/10/2002 | US20020004508 Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 01/10/2002 | US20020004503 Viricides |
| 01/10/2002 | US20020004499 Mixture of antibiotics; variations of releasing profiles |
| 01/10/2002 | US20020004489 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | US20020004076 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 01/10/2002 | US20020004051 Materials and methods for prevention or reduction of the severity of heartwater |
| 01/10/2002 | US20020004048 Hepatitis C virus asialoglycoproteins |
| 01/10/2002 | US20020004046 Includes use of neutralizing antibody, high affinity antibodies, and viricide (ribavirin, amantadine, rimantadine, or a neuraminidase inhibitor); useful for controlling/treating respiratory syncytial virus in young children |
| 01/10/2002 | US20020004043 Cellular and animal models for diseases associated with altered mitochondrial function |
| 01/10/2002 | EP1143805A3 Method for reducing incidence of ascites in poultry by aid of natamycin |
| 01/10/2002 | DE10030139A1 Verwendung von Phyllanthusbesandteilen zur Behandlung oder Prophylaxe von Infekten durch Flaviviridae Using Phyllanthusbesandteilen for the treatment or prophylaxis of infections by Flaviviridae |
| 01/10/2002 | DE10029671A1 Biotransformation von biologisch aktiven Verindungen aus verschiedenen chemischen Stoffklassen mittels der Enzyme Laccase und Manganperoxidase Biotransformation of biologically active Verindungen from different classes of chemical substances by means of enzymes laccase and manganese peroxidase |
| 01/10/2002 | CA2414884A1 Immunisation against chlamydia pneumoniae |
| 01/10/2002 | CA2414355A1 Amphipathic linear peptides and compositions containing same |
| 01/10/2002 | CA2414352A1 Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies |
| 01/10/2002 | CA2413753A1 Antifungal compounds and methods of use |
| 01/10/2002 | CA2413715A1 Grf2-binding proteins and applications thereof |
| 01/10/2002 | CA2413245A1 N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity |
| 01/10/2002 | CA2413243A1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders |
| 01/10/2002 | CA2413186A1 Extracellular matrix and cell adhesion molecules |
| 01/10/2002 | CA2413166A1 Acid-modified arabinogalactan protein composition |
| 01/10/2002 | CA2413128A1 Transporters and ion channels |
| 01/10/2002 | CA2412872A1 Protein modification and maintenance molecules |
| 01/10/2002 | CA2412292A1 Base analogues |
| 01/10/2002 | CA2412270A1 Pyrrole derivatives for treating aids |
| 01/10/2002 | CA2411692A1 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 01/10/2002 | CA2410658A1 Pyrroloquinolones as antiviral agents |
| 01/10/2002 | CA2410551A1 Heterodimeric fusion proteins |
| 01/10/2002 | CA2410476A1 Method for treatment and prevention of mastitis |
| 01/10/2002 | CA2406649A1 B7-like polynucleotides, polypeptides, and antibodies |
| 01/09/2002 | EP1170368A2 Immunization by inoculation of dna transcription unit |
| 01/09/2002 | EP1170367A1 BVDV virus-like particles |
| 01/09/2002 | EP1170289A2 Retroviral protease inhibiting compounds |
| 01/09/2002 | EP1170016A2 Urease-based vaccine against helicobacter infection |
| 01/09/2002 | EP1170014A1 Proteoglycan, a bioactive substance from plants |
| 01/09/2002 | EP1170013A1 Drugs, foods, drinks and feeds containing cocoa component |
| 01/09/2002 | EP1169480A1 Tissue-specific and pathogen-specific toxic agents and ribozymes |
| 01/09/2002 | EP1169465A1 Two-step immunization procedure against chlamydia infection |
| 01/09/2002 | EP1169457A2 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 01/09/2002 | EP1169456A1 Recombinant toxin a/toxin b vaccine against clostridium difficile |
| 01/09/2002 | EP1169453A1 Inhibition of viral infection using monovalent antigen-binding proteins |
| 01/09/2002 | EP1169448A1 Tumor necrosis factor homologs and nucleic acids encoding the same |
| 01/09/2002 | EP1169445A2 Human proteins and polynucleotides encoding them |
| 01/09/2002 | EP1169440A1 48 human secreted proteins |
| 01/09/2002 | EP1169346A1 48 human secreted proteins |
| 01/09/2002 | EP1169344A1 47 human secreted proteins |
| 01/09/2002 | EP1169342A2 Tuberculosis antigens and methods of use therefor |
| 01/09/2002 | EP1169340A1 Lantibiotic |
| 01/09/2002 | EP1169339A1 Macrocyclic peptides inhibiting the hepatitis c virus ns3 protease |
| 01/09/2002 | EP1169337A2 Steroid nitrates for the treatment of oxidative injury and endothelial dysfunction |
| 01/09/2002 | EP1169334A1 48 human secreted proteins |
| 01/09/2002 | EP1169333A1 49 human secreted proteins |
| 01/09/2002 | EP1169323A1 Beta-lactamase inhibiting compounds |
| 01/09/2002 | EP1169320A1 Farnesyl transferase inhibitors having a pyrrole structure and process for preparation thereof |
| 01/09/2002 | EP1169316A1 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them |
| 01/09/2002 | EP1169311A1 Oxazole and thiazole combinatorial libraries |
| 01/09/2002 | EP1169306A1 Dibenzoazulene derivatives for treating thrombosis, osteoporosis, arteriosclerosis |
| 01/09/2002 | EP1169298A2 Pharmaceutical compounds |
| 01/09/2002 | EP1169244A2 Metering valve |
| 01/09/2002 | EP1169082A1 Method of providing cosmetic/medical therapy |
| 01/09/2002 | EP1169063A2 Treatment of intracellular infection |
| 01/09/2002 | EP1169057A2 Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein |
| 01/09/2002 | EP1169046A1 Pulmonary delivery of protonated/acidified nucleic acids |
| 01/09/2002 | EP1169045A2 Immunomodulating polymers |
| 01/09/2002 | EP1169044A1 Use of fucosylated sialylated n-acetyl lactosamine carbohydrate structures for inhibition of bacterial adherence |
| 01/09/2002 | EP1169042A1 Dibenzo-azepine derivatives as alpha v integrin receptor antagonists |
| 01/09/2002 | EP1169041A2 Use of carbamic acid derivatives for the treatment of viral infections |
| 01/09/2002 | EP1169039A2 Pharmaceutical formulation comprising amoxycillin |
| 01/09/2002 | EP1169036A2 Anti-viral uses of leflunomide products |
| 01/09/2002 | EP1169031A1 Antimicrobial agents |
| 01/09/2002 | EP1169025A2 Transdermal drug delivery devices comprising a polyurethane drug reservoir |
| 01/09/2002 | EP1169005A2 Association of no-synthase inhibitor(s) and metabolic antioxidant(s) |
| 01/09/2002 | EP1168924A1 In vitro induction of antigen-specific t-cells using dendritic cell-tumor cell or dendritic cell-viral cell derived immunogens |
| 01/09/2002 | EP1168919A2 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion |
| 01/09/2002 | EP0789764B1 A novel family of protease inhibitors, and other biologic active substances |
| 01/09/2002 | EP0765151B1 Antibacterial oil-in-water emulsions |
| 01/09/2002 | EP0727978B1 Topical aromatic releasing compositions |
| 01/09/2002 | EP0495811B1 Production of genetically-engineered vaccines for aids and other retroviral diseases |
| 01/09/2002 | CN1330714A Virulence genes and proteins and their use |